Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed bimonthly journal that publishes
original articles describing
various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma,
Myeloma& Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia
and related ... click here for full Aims & Scope
Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed bimonthly journal that publishes
original articles describing
various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma,
Myeloma& Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia
and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent
scientific
developments in all areas related to lymphoma, myeloma and leukemia. Specific areas of interest include clinical
research and mechanistic
approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and
prognostic indicators; chemoprevention
strategies; multimodality therapy; and integration of various approaches.
Hide Aims & Scope
Senior Editor-in-Chief:
Sundar Jagannath, MD
This journal is now available on
ScienceDirect.
